PharVision Advisers’s OppFi OPFI Stock Holding History

PharVision Advisers’s Portfolio OPFI Stock Details OPFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,140	Closed	-$217K	–	916
2025 Q3	$217K	Buy	+19,140	New	+$215K	0.12%	445

Other funds holding OPFI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's OPFI Position: Q4 2025 in Review

PharVision Advisers sold out of OppFi (OPFI) in Q4 2025, closing a stake of 19,140 shares — an estimated $217K sold.

PharVision Advisers first reported a position in OPFI in Q3 2025 and held it in 1 quarter. The position peaked at $217K in Q3 2025. 142 funds tracked by Wall St. Rank hold OPFI as of Q4 2025.

PharVision Advisers reported no remaining OppFi position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 19,140 OppFi shares in Q4 2025, an estimated $217K.
PharVision Advisers first reported a position in OppFi in Q3 2025 and held it in 1 quarter.
PharVision Advisers's OppFi position peaked at $217K in Q3 2025.
142 funds tracked by Wall St. Rank held OppFi as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.